Back to Search
Start Over
Healthcare providers can expect to receive US$725 reimbursement from CMS when using NGS-based Sentosa SQ HIV-1 Genotyping Assay
- Source :
- Medical Letter on the CDC & FDA. January 30, 2022, 1008
- Publication Year :
- 2022
-
Abstract
- 2022 JAN 30 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Vela Diagnostics announced that its Sentosa® SQ HIV-1 Genotyping Assay [...]
Details
- Language :
- English
- ISSN :
- 15324648
- Database :
- Gale General OneFile
- Journal :
- Medical Letter on the CDC & FDA
- Publication Type :
- News
- Accession number :
- edsgcl.690210003